Michael A Koldobskiy

5PUBLICATIONS
28CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epigenetics (incl. genome methylation and epigenomics)Functional materialsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 29, 2026
Combination epigenetic-targeted therapy increases the immunogenicity of poorly immunogenic sarcomas.

|Mar 16, 2026
DNA Methylation Stochasticity Is Linked to Transcriptional Variability and Convergent Epigenetic Disruption across Genetic Subtypes of Acute Myeloid Leukemia.

Eleanor Hilgart, Weiqiang Zhou, Eduardo Martinez-Montes

|Feb 10, 2026
Convergence of aging- and rejuvenation-related epigenetic alterations on PRC2 targets.

Oscar Camacho, Michael A Koldobskiy, Pradeep Reddy

|Nov 20, 2025
DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency.

Thomas Köhnke, Daiki Karigane, Eleanor Hilgart

|Mar 12, 2024
DNA methylation landscapes in DIPG reveal methylome variability that can be modified pharmacologically.

Ashley R Tetens, Allison M Martin, Antje Arnold

Pageof 1

Frequent Collaborators

3 joint publications

Andrew P Feinberg

2 joint publications

Eleanor Hilgart

2 joint publications

Ravindra Majeti

2 joint publications

Eduardo Martinez-Montes